Zachary Long, DO
Plastic and Reconstructive Surgery · Honolulu, HINPI 1295142453
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 42.9% of the total. 2025 is the largest year on record at $1,379, more than ten times the $25 reported in 2020.
Across 56 payments — averaging $34.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$840
- Viiv Healthcare Company$472
- Revance Therapeutics, Inc.$284
- Motiva USA, LLC$145
- Mentor Worldwide LLC$57
- Gilead$55
- plus $104 from 4 others
What the payments were for
- Food & beverage$1,957100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $840 |
| Viiv Healthcare Company | 22 | $472 |
| Revance Therapeutics, Inc. | 6 | $284 |
| Motiva USA, LLC | 2 | $145 |
| Mentor Worldwide LLC | 3 | $57 |
| Gilead | 3 | $55 |
| TELA Bio, Inc. | 1 | $34 |
| Merz North America, Inc. | 1 | $33 |
| Smith+Nephew | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Honolulu
- Shim ChingHonolulu$49K
- Peter DeptulaHonolulu$18K
- Randolph WongHonolulu$7K
- Vincent NipHonolulu$7K
- Robert SchulzHonolulu$4K
- Matthew AdaniyaHonolulu$2K
- Michael PasqualeHonolulu$904
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.